2023 Form 5500 filing — Maze Therapeutics Inc 401k Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241010092344NAL0011330611001) for Maze Therapeutics Inc 401k Plan, reported by Maze Therapeutics Inc under EIN 82-2635018 and plan number 001. It reports 148 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).
Form 5500 2 · 2023
Filing snapshot
Net assets (EOY)$8MReported net assets$8,009,532
Participants148
Provider compensation$2K1 Schedule C row(s)$1,970
Schedules filedSchedule H, Schedule CLoaded schedules
- EFAST2 acknowledgement
- 20241010092344NAL0011330611001
- Plan sponsor
- Maze Therapeutics Inc
- EIN
- 82-2635018
- Plan number
- 001
- Location
- South San Francisco, CA
- Received date
- not reported in the loaded dataset
How to read this filing
- This is a single annual Form 5500 filing, identified by its EFAST2 acknowledgement id.
- Schedule chips (Sch H / I / C) show which schedules this filing includes.
- Net assets = total assets minus total liabilities (Schedule H/I).
- Fields a filing did not report are labeled not reported in the loaded dataset — never estimated.
- For the plan's full history, open the plan profile.
Schedule H · 2023
Reported financial snapshot
Reported figures as filed, in whole dollars. Only fields the filing reports are shown.
Reported balance (end of year)$8M total assets
Net assets$8MLiabilities$0
Full reported line items
- Total assets (EOY)
- $8,009,532
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $8,009,532
- Employer contributions
- $297,254
- Participant contributions
- $2,017,031
- Total income / additions
- $3,693,674
- Benefits paid
- $1,527,532
- Administrative expenses
- $1,970
- Total expenses
- $1,530,233
- Net increase / (decrease)
- $2,163,441
Schedule C
Reported service provider compensation
Compensation reported on the 2023 filing, ranked by reported total.
- 1
Frequently asked questions
- What does EFAST2 acknowledgement 20241010092344NAL0011330611001 cover?
- It is the 2023 Form 5500 filing for Maze Therapeutics Inc 401k Plan, reported by Maze Therapeutics Inc (EIN 82-2635018).
- Which Form 5500 schedules are attached to this 2023 filing?
- Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).